Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prostate health index selectively identifies clinically significant prostate cancer.
Loeb S, Sanda MG, Broyles DL, Shin SS, Bangma CH, Wei JT, Partin AW, Klee GG, Slawin KM, Marks LS, van Schaik RH, Chan DW, Sokoll LJ, Cruz AB, Mizrahi IA, Catalona WJ. Loeb S, et al. Among authors: broyles dl. J Urol. 2015 Apr;193(4):1163-9. doi: 10.1016/j.juro.2014.10.121. Epub 2014 Nov 15. J Urol. 2015. PMID: 25463993 Free PMC article.
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.
Sokoll LJ, Sanda MG, Feng Z, Kagan J, Mizrahi IA, Broyles DL, Partin AW, Srivastava S, Thompson IM, Wei JT, Zhang Z, Chan DW. Sokoll LJ, et al. Among authors: broyles dl. Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1193-200. doi: 10.1158/1055-9965.EPI-10-0007. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20447916 Free PMC article.
A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.
Catalona WJ, Partin AW, Sanda MG, Wei JT, Klee GG, Bangma CH, Slawin KM, Marks LS, Loeb S, Broyles DL, Shin SS, Cruz AB, Chan DW, Sokoll LJ, Roberts WL, van Schaik RH, Mizrahi IA. Catalona WJ, et al. Among authors: broyles dl. J Urol. 2011 May;185(5):1650-5. doi: 10.1016/j.juro.2010.12.032. Epub 2011 Mar 17. J Urol. 2011. PMID: 21419439 Free PMC article. Clinical Trial.
Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.
Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, Shin SS, Marshall LA, Alper MM, Morales AJ, Pavone ME, Behera MA, Zbella EA, Shapiro BS, Straseski JA, Broyles DL. Baker VL, et al. Among authors: broyles dl. Fertil Steril. 2018 Aug;110(3):506-513.e3. doi: 10.1016/j.fertnstert.2018.03.031. Epub 2018 Jun 28. Fertil Steril. 2018. PMID: 29960708 Free article.
Validation study of the Access antimüllerian hormone assay for the prediction of poor ovarian response to controlled ovarian stimulation.
Baker VL, Glassner MJ, Doody K, Schnell VL, Gracia C, Shin SS, Behera MA, Le Saint CM, Alper MM, Pavone ME, Zbella EA, Coddington CC, Marshall LA, Feinberg RF, Cooper AR, Straseski JA, Broyles DL. Baker VL, et al. Among authors: broyles dl. Fertil Steril. 2021 Aug;116(2):575-582. doi: 10.1016/j.fertnstert.2021.01.056. Epub 2021 Mar 31. Fertil Steril. 2021. PMID: 33812650 Free article.
Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting.
White J, Shenoy BV, Tutrone RF, Karsh LI, Saltzstein DR, Harmon WJ, Broyles DL, Roddy TE, Lofaro LR, Paoli CJ, Denham D, Reynolds MA. White J, et al. Among authors: broyles dl. Prostate Cancer Prostatic Dis. 2018 Apr;21(1):78-84. doi: 10.1038/s41391-017-0008-7. Epub 2017 Nov 20. Prostate Cancer Prostatic Dis. 2018. PMID: 29158509 Free PMC article.
15 results